Navigation Links
The Global Market for Intravascular Ultrasound Tools and Ancillary Equipment
Date:7/25/2013

RTNERSHIP, AGREEMENTS AND COLLABORATIONS,

2010-APRIL 2013 88

TABLE 46 DEVELOPMENTS - GEOGRAPHIC, SALES OR MANUFACTURING EXPANSION,

2010-APRIL 2013 90

TABLE 47 DEVELOPMENTS - ACQUISITIONS, 2010-APRIL 2013 91

TABLE 48 JAPANESE IVUS MARKET BY PRODUCTS, THROUGH 2017 ($ MILLIONS) 96

TABLE 49 JAPANESE IVUS MARKET BY APPLICATIONS, THROUGH 2017 ($ MILLIONS) 96

TABLE 50 JAPANESE IVUS MARKET BY END USERS, THROUGH 2017 ($ MILLIONS) 97

TABLE 51 U.S. IVUS MARKET BY PRODUCTS, THROUGH 2017 ($ MILLIONS) 99

TABLE 52 U.S. IVUS MARKET BY APPLICATION, THROUGH 2017 ($ MILLIONS) 100

TABLE 53 U.S. IVUS MARKET BY END USER, THROUGH 2017 ($ MILLIONS) 100

TABLE 54 EUROPEAN IVUS MARKET BY PRODUCT, THROUGH 2017 ($ MILLIONS) 103

TABLE 55 EUROPEAN IVUS MARKET BY APPLICATION, THROUGH 2017 ($ MILLIONS) 103

TABLE 56 EUROPEAN IVUS MARKET BY END USER, THROUGH 2017 ($ MILLIONS) 104

TABLE 57 ASIAN AND ROW IVUS MARKET BY PRODUCT, THROUGH 2017 ($ MILLIONS) 106

TABLE 58 ASIAN AND ROW IVUS MARKET BY APPLICATION, THROUGH 2017 ($

MILLIONS) 107

TABLE 59 ASIAN AND ROW IVUS MARKET BY END USER, THROUGH 2017 ($

MILLIONS) 108

TABLE 60 LIST OF U.S. PATENTS, 2010-2013 110

TABLE 61 LIST OF EUROPE PATENTS, 2010-2013 114

TABLE 62 LIST OF JAPAN PATENTS, 2010-2011 115

TABLE 63 BOSTON SCIENTIFIC CORPORATION IVUS AND RELATED PRODUCT

PORTFOLIO 119

TABLE 64 BOSTON SCIENTIFIC CORPORATION NET SALES AND R&D EXPENDITURE,

2010-2012 ($ MILLIONS) 120

TABLE 65 BOSTON SCIENTIFIC CORPORATION NET SALES BY REGION, 2010-2012 ($

MILLIONS) 120

TABLE 66 BOSTON SCIENTIFIC CORPORATION NET SALES BY BUSINESS SEGMENTS,

2010-2012 ($ MILLIONS) 120

TABLE 67 INFRAREDX IVUS AND RELATED PRODUCT PORTFOLIO 124

TABLE 68 TERUMO CORPORATION IVUS AND RELATED PRODUCT PORTFOLIO 133

TAB
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013
2. Computational Biology Market - Global Industry Analysis, Size, Share, Growth, Trend
3. Water Treatment Industry Reports: Equipment Research for US & Global Wastewater Treatment Markets
4. Global Herbal Supplements and Remedies Industry
5. Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) Is Expected to Reach USD 5.0 Billion Globally in 2018: Transparency Market Research
6. ResearchMoz.us: Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growt
7. Global Insulin Delivery Devices Market Forecast to 2017
8. El Movimiento Internacional por el Autocuidado pasa a ser global
9. International Self-Care Movement Goes Global to Promote This Underexploited Weapon in Fighting Killer Diseases
10. McCann Health and dacadoo ag Form Global Strategic Partnership To Expand Mobile Health & Fitness Tracking System
11. Global Decubitus Ulcer Treatment Products Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... Mass. , July 27, 2015 ... of Merck KGaA of Darmstadt, ... with celares GmbH to provide pegylation services to ... service offering enabled by the collaboration includes feasibility ... milligram to gram quantities required for pilot and ...
(Date:7/27/2015)... , July 27, 2015  Endo International plc (NASDAQ: ... 2015 financial results before the open of the U.S. financial ... management team will host a conference call and webcast at ... number to access the call is U.S./ Canada ... is 93183256. Please dial in 10 minutes prior to the ...
(Date:7/27/2015)... PITTSBURGH , July 27, 2015  Mylan N.V. ... regarding Teva,s (NYSE and TASE: TEVA) announcement of its ... and its withdrawal of its unsolicited expression of interest ... Robert J. Coury stated: "We congratulate Teva on ... their continued, and potentially enhanced, commitment to the generics ...
Breaking Medicine Technology:EMD Millipore Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH 2EMD Millipore Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH 3Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 2Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 3Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 4Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 5Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 6Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 7Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 8Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit 9
... Safety Profile of the Intramuscular Formulation,of Peramivir ... BIRMINGHAM, Ala., June 18, 2007 /PRNewswire-FirstCall/ --,BioCryst ... I,clinical studies of an intramuscular (i.m.) formulation ... of Influenza Conference in,Toronto, Ontario, Canada. This ...
... 70 abstracts highlight VELCADE efficacy in broad range,of ... Mass., June 19, 2007 /PRNewswire-FirstCall/ --,Millennium Pharmaceuticals, Inc. ... therapy with unsurpassed single-agent,efficacy for patients with previously ... upcoming International Myeloma,Workshop (IMW) in Kos, Greece, June ...
Cached Medicine Technology:BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 2BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 3BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 4BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 5BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8
(Date:7/27/2015)... ... July 28, 2015 , ... Dr. Robert G. Schwartz ... practice has teamed up with Realief Neuropathy Centers in order to offer his patients ... the signs and symptoms of peripheral neuropathy. , Peripheral neuropathy is a disease caused ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular risk factors, ... brain volumes that may be early indicators of Alzheimer’s disease and dementia, according ... that vascular risk factors damage the brain and can result in cognitive impairment,” ...
(Date:7/27/2015)... Madre, CA (PRWEB) , ... July 27, 2015 ... ... of healthcare today, especially in wound center management. Earlier this year Wound ... wound care education and training for WCA wound centers. Customized learning paths ...
(Date:7/27/2015)... Los Angeles, CA (PRWEB) , ... July 27, 2015 , ... ... See the Derm for 7 Common Skin Issues,” describes common skin issues such as ... the technology available for cosmetic dermatologists to treat them. The treatment options listed include ...
(Date:7/27/2015)... ... July 27, 2015 , ... Send ... and mobile collaboration, announced today the latest software release for ... and other feature enhancements. , This software release gives the widely used online ...
Breaking Medicine News(10 mins):Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3Health News:The Latest Treatment Options for Seven Common Skin Issues 2Health News:Send Word Now Announces Release of New User Interface for its Award-Winning Mass Notification Service 2
... a key molecule that controls the growth, spread and survival ... toward new and better treatment options for pancreatic cancer . ... Beta molecule plays in pancreatic cancer and that they have ... and survival through its effect on NF Kappa B -- ...
... the drug alendronate (Fosamax) can reduce the risk of vertebral ... not osteoporosis. 3,737 postmenopausal women between ages 55 and 80 ... -2.5 were evaluated . About half the women randomly received ... thereafter while the other half took a placebo. ,The ...
... its growth factors aren’t just produced in the pancreas, but ... areas of the brain//, the result can be brain cell ... people with Alzheimer’s. ,The research was conducted in rats, ... IGF I and IGF II were produced in the nerve ...
... well known that HIV patients are at an increased risk ... study shows // aggressive antiretroviral therapy may help lower that ... antiretroviral therapy was associated with a lower incidence of Kaposi ... on more than 7,300 patients infected with HIV and the ...
... Intravenous administration of the drug tezosentan did not improve worsening ... failure // despite high hopes. The above fact was found ... to date. The study was conducted to evaluate if something ... order to speed up hospital discharge and prevent them from ...
... that how much we drink may be decided by a ... gene called DRD2 Taq1A(C32806T) polymorphism and social alcohol drinking may ... stronger gene of this type will tend to drink alcohol ... The gene is responsible for enhancing the pleasure that is ...
Cached Medicine News:
... camera system for high resolution photomicrography. The ... of the highest color fidelity, resolution and ... expect perfect images due to many unique ... innovative readout modes. The Leica DFC480 is ...
This compact photomicrographic system assures simple operation to achieve the exposure accuracy required for sophisticated photomicrography in most research and clinical environments....
... Geometric Data Hemastainer. Formulated to ... quality control tested on human ... staining and absence of precipitate. ... a minimum of eight hours ...
... Stat Stain is ideal for stat, routine ... blood smears (10-15 seconds) and bone marrow ... finely dispersed stain particles which yield excellent ... many of the steps involved in the ...
Medicine Products: